Department of Internal Medicine 1, Shimane University Faculty of Medicine, 89-1 Enya-cho, Izumo, Shimane, 693-8501, Japan.
Department of Nephrology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, 113-8519, Japan.
CEN Case Rep. 2021 May;10(2):294-300. doi: 10.1007/s13730-020-00561-y. Epub 2021 Jan 4.
Osteomalacia is a systemic metabolic bone disease. Hypophosphatemia is one of the most important causes of impaired mineralization. Here, we describe a case of osteomalacia associated with atypical renal tubular acidosis. A 43-year-old woman was admitted to our hospital due to sustained unrelieved bilateral flank pain. She had a history of fragile fracture with vitamin D deficiency and had been treated with active vitamin D. On admission, she presented with hypophosphatemia, hypocalcemia, high bone-specific alkaline phosphatase level, bone pain, and low bone mineral density. Multiple areas of uptake were also confirmed by bone scintigraphy, and she was diagnosed with osteomalacia. An increased dose of alfacalcidol was initiated for her vitamin D deficiency; her symptoms remained unstable and unrelieved. Her blood gas examination revealed metabolic acidosis without an increase in the anion gap (HCO 11.8 mEq/L, anion gap 3.2 mEq/L). Tubular dysfunction, tubular damage, kidney stones, and inadequate urinary acidification were all observed, suggesting the presence of renal tubular acidosis from a combination of both distal and proximal origin. She also had overt proteinuria, decreased renal function, and hypothalamic hypogonadism. In addition to alfacalcidol, sodium bicarbonate and oral phosphorus supplementation were initiated. After this prescription, her pain dramatically improved in association with the restoration of acid-base balance and electrolytes; renal dysfunction and proteinuria were unaltered. This case indicated that careful assessments of tubular function and acid-base balance are essential for the management of osteomalacia in addition to the evaluation of the calcium/phosphate balance and vitamin D status.
骨软化症是一种全身性代谢性骨病。低磷血症是矿物质化受损的最重要原因之一。在这里,我们描述了一例与非典型肾小管酸中毒相关的骨软化症。一名 43 岁女性因持续性双侧腰痛而被收入我院。她曾有维生素 D 缺乏性脆性骨折病史,并接受过活性维生素 D 治疗。入院时,她表现为低磷血症、低钙血症、高骨特异性碱性磷酸酶水平、骨痛和低骨密度。骨闪烁显像也证实了多处摄取,她被诊断为骨软化症。她开始接受阿尔法骨化醇治疗维生素 D 缺乏症;但她的症状仍然不稳定且未缓解。她的血气检查显示代谢性酸中毒,阴离子间隙无增加(HCO 11.8 mEq/L,阴离子间隙 3.2 mEq/L)。观察到肾小管功能障碍、肾小管损伤、肾结石和尿酸化不足,提示存在由远端和近端起源共同引起的肾小管酸中毒。她还伴有明显蛋白尿、肾功能下降和下丘脑性腺功能减退。除了阿尔法骨化醇,还开始给予碳酸氢钠和口服磷补充剂。在这个处方之后,她的疼痛显著改善,同时酸碱平衡和电解质也得到了恢复;肾功能和蛋白尿没有改变。这个病例表明,除了评估钙/磷平衡和维生素 D 状态外,对肾小管功能和酸碱平衡进行仔细评估对于骨软化症的治疗至关重要。